ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,942.64
-0.27%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.4505
0.12%
Brent Oil
82.065
-0.46%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Aerpio Pharmaceuticals Inc (ARPO)

  7. Aerpio Pharmaceuticals Inc (ARPO) ニュース

ARPO

Aerpio Pharmaceuticals (ARPO)

Aerpio Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ARPO
日付受信時刻ニュースソース見出しコード企業名
2023/06/2119 : 03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/2119 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/2119 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/2119 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/2119 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/2119 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/1704 : 14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/06/0608 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/05/0605 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/05/0407 : 55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/04/2902 : 25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/04/2901 : 47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/04/2901 : 43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/04/0608 : 33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/04/0505 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/3005 : 21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/3005 : 19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/3005 : 07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/2919 : 02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/2905 : 08Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/2821 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/0322 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/03/0306 : 11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/02/1420 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/02/1103 : 05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2023/01/0506 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2022/11/2820 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2022/11/1006 : 16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2022/11/0922 : 20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
2022/11/0720 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARPOAerpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARPO

最近閲覧した銘柄

USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
NYSE
DIS
Walt Disney
USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
NYSE
AXP
American Express
NYSE
CVX
Chevron
CCOM
US100
US Tech 100
NASDAQ
NVDA
NVIDIA
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有